Research Article
Overall Survival Analyses following Adjuvant Chemotherapy or Nonadjuvant Chemotherapy in Patients with Stage IB Non-Small-Cell Lung Cancer
Table 4
Subgroup analyses stratified by tumor size for overall survival.
| | ≤20 mm | 21 mm–30 mm | 31 mm–40 mm | HR | 95%CI | | HR | 95%CI | | HR | 95%CI | |
| Age | <60 | 1 | | | 1 | | | 1 | | | 61–75 | 1.343 | 1.153–1.563 | <0.001 | 1.675 | 1.407–1.993 | <0.001 | 1.479 | 1.333–1.640 | <0.001 | ≥75 | 1.927 | 1.641–2.264 | <0.001 | 2.525 | 2.112–3.018 | <0.001 | 2.335 | 2.097–2.600 | <0.001 |
| Gender | Male | 1 | | | 1 | | | 1 | | | Female | 0.669 | 0.606–0.739 | <0.001 | 0.725 | 0.657–0.801 | <0.001 | 0.722 | 0.678–0.770 | <0.001 |
| History of chemotherapy | Nonadjuvant chemotherapy | 1 | | | 1 | | | 1 | | | Adjuvant chemotherapy | 1.068 | 0.919–1.241 | 0.394 | 0.845 | 0.724–0.986 | 0.032 | 0.912 | 0.833–1.000 | 0.049 |
|
|